Geode Capital Management LLC Has $2.13 Million Stock Position in Aemetis, Inc. (NASDAQ:AMTX)

Geode Capital Management LLC boosted its holdings in shares of Aemetis, Inc. (NASDAQ:AMTX) by 7.7% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 924,293 shares of the specialty chemicals company’s stock after purchasing an additional 66,031 shares during the period. Geode Capital Management LLC’s holdings in Aemetis were worth $2,126,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. State Street Corp lifted its position in shares of Aemetis by 36.1% during the 3rd quarter. State Street Corp now owns 699,089 shares of the specialty chemicals company’s stock worth $1,608,000 after buying an additional 185,304 shares during the last quarter. Rhumbline Advisers raised its stake in Aemetis by 2,837.1% during the second quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock worth $157,000 after acquiring an additional 50,528 shares in the last quarter. Susquehanna Fundamental Investments LLC lifted its holdings in shares of Aemetis by 287.4% in the second quarter. Susquehanna Fundamental Investments LLC now owns 126,078 shares of the specialty chemicals company’s stock worth $379,000 after acquiring an additional 93,536 shares during the last quarter. Wellington Management Group LLP bought a new position in shares of Aemetis in the third quarter worth about $177,000. Finally, FMR LLC boosted its stake in shares of Aemetis by 68.2% in the 3rd quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock valued at $52,000 after purchasing an additional 9,137 shares in the last quarter. Institutional investors and hedge funds own 27.02% of the company’s stock.

Wall Street Analysts Forecast Growth

AMTX has been the subject of a number of research analyst reports. HC Wainwright reiterated a “buy” rating and set a $28.00 price objective on shares of Aemetis in a research report on Monday, December 23rd. StockNews.com upgraded shares of Aemetis to a “sell” rating in a report on Friday, January 3rd. One analyst has rated the stock with a sell rating, one has issued a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $12.95.

Aemetis Price Performance

NASDAQ:AMTX opened at $2.90 on Wednesday. Aemetis, Inc. has a one year low of $2.10 and a one year high of $7.03. The company has a market cap of $144.23 million, a PE ratio of -1.28 and a beta of 1.47. The firm’s 50 day simple moving average is $3.27 and its 200 day simple moving average is $2.97.

Aemetis (NASDAQ:AMTX) last issued its quarterly earnings results on Tuesday, November 12th. The specialty chemicals company reported ($0.38) EPS for the quarter, topping analysts’ consensus estimates of ($0.47) by $0.09. The business had revenue of $81.44 million for the quarter, compared to analyst estimates of $77.79 million. During the same quarter last year, the firm posted ($0.59) EPS. Equities research analysts expect that Aemetis, Inc. will post -2.02 EPS for the current year.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.